Royalty Adjustment. In the event that the Royalty Rates payable to NEOMED negatively impacts the ability of Artelo, its Affiliates and sublicensees to maximize the Net Sales or earn reasonable profit thereon during the Royalty Term, but after the expiration of the last to expire Valid Claim in the applicable country, then the Parties agree to negotiate in good faith an adjustment to the royalty rates applicable to such country.
Appears in 5 contracts
Samples: Material and Data Transfer, Option and License Agreement, Material and Data Transfer, Option and License Agreement (Artelo Biosciences, Inc.), Material and Data Transfer, Option and License Agreement (Artelo Biosciences, Inc.)
